Versant Venture Management, LLC — 13F Holdings & Portfolio
CIK 1560009 · latest 13F-HR filed 2026-05-05
Versant Venture Management, LLC manages $141.4M in 13F-reported U.S. long-equity assets across 8 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are GLUE (37.00%), IPSC (19.44%), LENZ (17.19%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 1 new position, exited 0, added to 1, and trimmed 6.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$141.4M
Long-equity book
8
Distinct positions
2026-03-31
Filed 2026-05-05
+1 / −0 / ↑1 / ↓6
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Trims
- Lenz Therapeutics, Inc.-$18.2M -42.8%
- Monte Rosa Therapeutics, Inc.-$16.4M -23.9%
- Jade Biosciences, Inc.-$2.1M -8.9%
- CRISPR Therapeutics AG-$724.8K -9.3%
- Tempest Therapeutics, Inc.-$331.8K -42.9%
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | Monte Rosa Therapeutics, Inc. | GLUE | 61225M102 | $52.3M | 37.00% | 3,180,780 | SH |
| 2 | Century Therapeutics, Inc. | IPSC | 15673T100 | $27.5M | 19.44% | 12,166,109 | SH |
| 3 | Lenz Therapeutics, Inc. | LENZ | 52635N103 | $24.3M | 17.19% | 2,656,888 | SH |
| 4 | Jade Biosciences, Inc. | JBIO | 008064206 | $21.4M | 15.16% | 1,525,820 | SH |
| 5 | Contineum Therapeutics, Inc. | CTNM | 21217B100 | $7.1M | 5.01% | 542,628 | SH |
| 6 | CRISPR Therapeutics AG | CRSP | H17182108 | $7.1M | 5.01% | 148,831 | SH |
| 7 | Skye Bioscience, Inc. | SKYE | 83086J200 | $1.2M | 0.87% | 2,007,704 | SH |
| 8 | Tempest Therapeutics, Inc. | TPST | 87978U108 | $442.4K | 0.31% | 269,772 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-05 | $141.4M | 8 | 0001193125-26-206555 |
| 2025-12-31 | 2026-02-12 | $151.1M | 7 | 0001193125-26-048719 |